Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
mapk decrease » marked decrease (Expand Search), small decrease (Expand Search), mean decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ largest » _ large (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
mapk decrease » marked decrease (Expand Search), small decrease (Expand Search), mean decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ largest » _ large (Expand Search)
-
1
-
2
-
3
-
4
BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers.
Published 2024“…<p>(<b>A)</b> Changes in TEER with increasing culture time on days 1–22. …”
-
5
-
6
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”
-
7
-
8
-
9
Table 2_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
10
Image 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.pdf
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
11
Table 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
12
Data Sheet 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.zip
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Distribution of individual change in trust in science before and after the pandemic (n = 10,000).
Published 2025Subjects: -
20